Literature DB >> 17389605

Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens.

Jörg Andrä1, Daniel Monreal, Guillermo Martinez de Tejada, Claudia Olak, Gerald Brezesinski, Susana Sanchez Gomez, Torsten Goldmann, Rainer Bartels, Klaus Brandenburg, Ignacio Moriyon.   

Abstract

The peptide NK-2 is an effective antimicrobial agent with low hemolytic and cytotoxic activities and is thus a promising candidate for clinical applications. It comprises the alpha-helical, cationic core region of porcine NK-lysin a homolog of human granulysin and of amoebapores of pathogenic amoeba. Here we visualized the impact of NK-2 on Escherichia coli by electron microscopy and used NK-2 as a template for sequence variations to improve the peptide stability and activity and to gain insight into the structure/function relationships. We synthesized 18 new peptides and tested their activities on seven Gram-negative and one Gram-positive bacterial strains, human erythrocytes, and HeLa cells. Although all peptides appeared unordered in buffer, those active against bacteria adopted an alpha-helical conformation in membrane-mimetic environments like trifluoroethanol and negatively charged phosphatidylglycerol (PG) liposomes that mimick the cytoplasmic membrane of bacteria. This conformation was not observed in the presence of liposomes consisting of zwitterionic phosphatidylcholine (PC) typical for the human cell plasma membrane. The interaction was paralleled by intercalation of these peptides into PG liposomes as determined by FRET spectroscopy. A comparative analysis between biological activity and the calculated peptide parameters revealed that the decisive factor for a broad spectrum activity is not the peptide overall hydrophobicity or amphipathicity, but the possession of a minimal positive net charge plus a highly amphipathic anchor point of only seven amino acid residues (two helical turns).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389605     DOI: 10.1074/jbc.M608920200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Online monitoring of metabolism and morphology of peptide-treated neuroblastoma cancer cells and keratinocytes.

Authors:  Sabine Drechsler; Jörg Andrä
Journal:  J Bioenerg Biomembr       Date:  2011-06-04       Impact factor: 2.945

2.  Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo.

Authors:  Susana Sánchez-Gómez; Bostjan Japelj; Roman Jerala; Ignacio Moriyón; Mirian Fernández Alonso; José Leiva; Sylvie E Blondelle; Jörg Andrä; Klaus Brandenburg; Karl Lohner; Guillermo Martínez de Tejada
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

3.  Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol.

Authors:  Jörg Andrä; Torsten Goldmann; Christoph M Ernst; Andreas Peschel; Thomas Gutsmann
Journal:  J Biol Chem       Date:  2011-04-07       Impact factor: 5.157

4.  In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori.

Authors:  Morris O Makobongo; Tchelet Kovachi; Hanan Gancz; Amram Mor; D Scott Merrell
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

5.  Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides.

Authors:  Ramamourthy Gopal; Chang Ho Seo; Peter I Song; Yoonkyung Park
Journal:  Amino Acids       Date:  2012-08-23       Impact factor: 3.520

6.  Anion transport properties of amine and amide-sidechained peptides are affected by charge and phospholipid composition.

Authors:  Lei You; Ruiqiong Li; George W Gokel
Journal:  Org Biomol Chem       Date:  2008-06-16       Impact factor: 3.876

7.  The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.

Authors:  Christoph Gelhaus; Thomas Jacobs; Jörg Andrä; Matthias Leippe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

8.  The use of MALDI-TOF-MS and in silico studies for determination of antimicrobial peptides' affinity to bacterial cells.

Authors:  Santi M Mandal; Ludovico Migliolo; Octavio L Franco
Journal:  J Am Soc Mass Spectrom       Date:  2012-08-25       Impact factor: 3.109

9.  Effects of antimicrobial peptides on methanogenic archaea.

Authors:  C Bang; A Schilhabel; K Weidenbach; A Kopp; T Goldmann; T Gutsmann; R A Schmitz
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

10.  Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity.

Authors:  Xinghong Zhao; Xiaoqi Wang; Rhythm Shukla; Raj Kumar; Markus Weingarth; Eefjan Breukink; Oscar P Kuipers
Journal:  Front Microbiol       Date:  2021-06-17       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.